Tag: gastric ulcers market drivers

Uncover key drivers, emerging technologies, and competitive movements shaping the gastric ulcers market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Gastric Ulcers Market size between 2026 and 2035?

The gastric ulcers market has shown strong expansion in recent years. It is projected to increase from $4.53 billion in 2025 to $4.78 billion in 2026, at a compound annual growth rate (CAGR) of 5.5%. Historically, this growth can be attributed to the prevalence of h pylori infection, widespread use of antacids, availability of antibiotics, hospital-based GI treatments, and adoption of endoscopic diagnosis.

The market for gastric ulcers is anticipated to experience consistent expansion over the upcoming years. This market is projected to reach $5.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.9%. This expansion during the projection period stems from factors such as the creation of advanced acid-suppression medications, the need for ongoing ulcer treatment, a rise in outpatient services, enhancements in diagnostic technologies, and an increase in lifestyle-related health conditions. Key developments expected in the forecast timeframe involve a greater reliance on proton pump inhibitors, an increasing emphasis on eradicating helicobacter pylori, the proliferation of combination drug treatments, the broadening of non-invasive diagnostic techniques, and heightened public understanding of gastrointestinal disorders.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17160&type=smp

Which Drivers Are Impacting Market Performance In The Gastric Ulcers Market?

The expanding elderly demographic is projected to drive the future expansion of the gastric ulcers market. This demographic typically encompasses individuals 65 years and older, who have distinct health concerns associated with aging. Growth in the geriatric population stems from progress in healthcare, resulting in extended life spans and a decrease in birth rates across numerous global regions. Gastric ulcers are frequently observed among the elderly because of elevated NSAID usage and reduced mucosal defense, which often escalates the risk of complications. For example, data from January 2024, provided by the Population Reference Bureau (PRB), a US-based private non-profit organization, indicates that the population of Americans aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050, marking a 47% rise. Furthermore, the proportion of this demographic within the total population is forecasted to climb from 17% to 23%. This demographic transition points to a notable aging pattern within the U.S. population. These projections underscore the growing necessity of catering to the requirements of older adults across diverse sectors. Consequently, the expanding geriatric population is fueling the advancement of the gastric ulcers market.

Which Segments Are Contributing To The Growth Of The Gastric Ulcers Market?

The gastric ulcers market covered in this report is segmented –

1) By Drug Class: Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes

2) By Diagnosis: Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:

1) By Proton Pump Inhibitors (PPI): Omeprazole, Lansoprazole, Pantoprazole, Esomeprazole, Rabeprazole

2) By H2 Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine

3) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate

4) By Antibiotics: Amoxicillin, Clarithromycin, Metronidazole, Tetracycline

5) By Cytoprotective Agents: Sucralfate, Misoprostol, Bismuth Subsalicylate

6) By Other Drug Classes: Prostaglandin Analogues, Prokinetic Agents, Herbal And Alternative Medications, Combination Therapies

Which Trends Are Influencing The Performance And Direction Of The Gastric Ulcers Market?

Leading companies in the gastric ulcer market are concentrating on developing innovative products, such as new formulations of drugs, to improve treatment efficacy and minimize side effects. New formulation drugs refer to medications created with novel combinations of active ingredients, delivery systems, or dosage forms to enhance their effectiveness, safety, and patient adherence. For instance, in June 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical preparation manufacturing company, launched Rabeprazole + Levosulpiride SR Capsules to provide enhanced relief for conditions such as gastro-oesophageal reflux disease (GERD) and other gastrointestinal tract (GIT) disorders. These products combine a proton pump inhibitor and a prokinetic agent, effectively treating gastrointestinal disorders like gastroesophageal reflux disease (GERD) and gastric ulcers. This formulation not only reduces gastric acid secretion but also enhances gastric motility, offering comprehensive relief from symptoms such as heartburn and indigestion.

Who Are The Prominent Global Companies Shaping The Gastric Ulcers Market Landscape?

Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

Which Region Currently Holds The Largest Share Of The Gastric Ulcers Market?

North America was the largest region in the gastric ulcers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Gastric Ulcers Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=17160&type=smp

Browse Through More Reports Similar to the Global Gastric Ulcers Market 2026, By The Business Research Company

Duodenal Ulcer Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/duodenal-ulcer-treatment-global-market-report

Peptic Ulcer Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report

Pressure Ulcers Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/pressure-ulcers-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Market Size Estimates For The Gastric Ulcers Market?

In the past few years, the size of the gastric ulcers market has robustly expanded. Anticipated to escalate from $4.29 billion in 2024 to $4.53 billion in 2025, the market is projected to progressively grow at a compound annual growth rate (CAGR) of 5.6%. The expansion in the historic era is generally credited to the surge in helicobacter pylori infections cases, amplified utilization of nonsteroidal anti-inflammatory drugs (NSAIDs), mounting global geriatric populace, escalating campaigns promoting gastric ulcer prevention, and a rise in stress-related disorder incidents.

The market size of gastric ulcers is predicted to experience substantial growth over the coming years, reaching $5.55 billion in 2029 with a compound annual growth rate (CAGR) of 5.2%. This predicted growth over the forecast period can be ascribed to advancements in diagnostic methodologies, the increasing prevalence of unhealthy eating habits, progression in therapeutic alternatives inclusive of proton pump inhibitors (PPIs), an aging population leading to an escalated disease load, and the evolution of healthcare systems in up-and-coming markets. Notable developments anticipated during the forecast period comprise a shift towards combination therapies for increased effectiveness, a growing inclination toward minimally invasive treatment methods, the incorporation of digital health strategies in disease control, an escalating need for over-the-counter (OTC) ulcer drugs, and the enlargement of personalized medicine strategies in ulcer therapy.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17160&type=smp

Which Industry Forces Are Driving The Gastric Ulcers Market Forward?

Anticipated growth in the gastric ulcers market is linked to the rising geriatric population. This demographic generally includes individuals aged 65 years and above, who are distinguished by unique health concerns associated with old age. An upsurge in this aging population results from advancements in healthcare that lead to increased life expectancy and falling birth rates in numerous global regions. Gastric ulcers are prevalent among senior citizens due to their frequent use of NSAIDs and reduced mucosal protective capabilities, often leading to elevated risk of complications. For example, data from the Population Reference Bureau (PRB), a private non-profit organization based in the US, states that in January 2024, the American population of people aged 65 and above is projected to rise from 58 million in 2022 to 82 million by 2050, demonstrating a 47% increase. Furthermore, the estimations anticipate the rise of this demographic’s distribution in the overall population from 17% to 23%. Such an increase designates a substantial age trend within the American populace. These statistics emphasize the escalating significance of catering to older adults’ requirements across various sectors. Consequently, this rise in the geriatric population is stimulating the growth of the gastric ulcers market.

How Is The Gastric Ulcers Market Organized By Different Segments?

The gastric ulcersmarket covered in this report is segmented –

1) By Drug Class: Proton Pump Inhibitors (PPI); H2 Antagonists; Antacids; Antibiotics; Cytoprotective Agents; Other Drug Classes

2) By Diagnosis: Stool Test; Endoscopy; Imaging Tests; Computed Tomography (CT) Scan; X-ray; Blood Tests; Other Diagnosis

3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels

5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End Users

Subsegments:

1) By Proton Pump Inhibitors (PPI): Omeprazole; Lansoprazole; Pantoprazole; Esomeprazole; Rabeprazole

2) By H2 Antagonists: Ranitidine; Famotidine; Cimetidine; Nizatidine

3) By Antacids: Calcium Carbonate; Magnesium Hydroxide; Aluminum Hydroxide; Sodium Bicarbonate

4) By Antibiotics: Amoxicillin; Clarithromycin; Metronidazole; Tetracycline

5) By Cytoprotective Agents: Sucralfate; Misoprostol; Bismuth Subsalicylate

6) By Other Drug Classes: Prostaglandin Analogues; Prokinetic Agents; Herbal And Alternative Medications; Combination Therapies

What Current And Upcoming Trends Are Shaping The Gastric Ulcers Market?

Key players in the gastric ulcer marketplace are channeling their efforts towards creating novel products like unique drug formulations to boost treatment efficiency and minimize adverse effects. New formatted medicines pertain to drugs that are innovatively combined with active compounds, delivery methodologies, or dosage formats to augment their efficiency, safety, and patient adherence. For illustration, in June 2024, an Indian pharmaceutical preparation manufacture firm, Akums Drugs and Pharmaceuticals Ltd. introduced Rabeprazole + Levosulpiride SR Capsules to offer increased alleviation for ailments such as gastro-oesophageal reflux disease (GERD) and other gastrointestinal tract (GIT) disorders. These products blend a proton pump inhibitor with a prokinetic agent, adeptly tackling gastrointestinal diseases like GERD and gastric ulcers. This concoction not only curtails gastric acid secretion but also ameliorates gastric motility, affording extensive relief from symptoms like heartburn and upset stomach.

Who Are The Primary Market Leaders In The Gastric Ulcers Market?

Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Amgen Inc., Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

How Do Regional Dynamics Influence The Gastric Ulcers Market Performance?

North America was the largest region in the gastric ulcers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=17160&type=smp

Browse Through More Reports Similar to the Global Gastric Ulcers Market 2025, By The Business Research Company

Gastric Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Gastric Cancer Drugs Global Market 2025

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market

Gastric Volvulus Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Gastric Ulcers Market Expected To Become By 2029 Compared With Its 2025 Level?

The gastric ulcers market size has experienced significant growth in recent years. It is projected to expand from $4.29 billion in 2024 to $4.53 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.6%. The market’s past expansion can be ascribed to the increasing prevalence of helicobacter pylori infections, a greater utilization of nonsteroidal anti-inflammatory drugs (NSAIDs), the global rise in the geriatric population, enhanced awareness initiatives for gastric ulcer prevention, and an uptick in stress-related disorders.

The gastric ulcers market is poised for robust expansion over the coming years. It is projected to reach $5.55 billion by 2029, expanding at a compound annual growth rate (CAGR) of 5.2%. This anticipated growth during the forecast period is driven by several factors, such as enhanced diagnostic methods, the prevalence of unhealthy eating patterns, progress in therapeutic alternatives like proton pump inhibitors (PPIs), an increasingly older demographic leading to a greater disease load, and the development of healthcare facilities in developing economies. Key developments expected within this period encompass a move towards combination therapies for improved effectiveness, an increasing inclination for less invasive treatment methods, the incorporation of digital health tools in managing the condition, a heightened demand for over-the-counter (OTC) medications for ulcers, and the broader application of personalized medicine strategies in ulcer care.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17160&type=smp

Which Drivers Are Shaping The Gastric Ulcers Industry’s Market Share?

The expanding older adult demographic is projected to boost the expansion of the gastric ulcers market in the foreseeable future. This demographic typically includes individuals 65 years and above, who have particular health needs associated with aging. The rise in this age group stems from healthcare improvements extending life expectancy and reduced birth rates across numerous global regions. Gastric ulcers frequently affect the geriatric population because of greater NSAID usage and diminished mucosal defense, often resulting in elevated complication risks. For example, in January 2024, data from the Population Reference Bureau (PRB), a US-based private non-profit, indicates that the number of Americans aged 65 and older is predicted to climb from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Furthermore, this group’s share of the total population is expected to increase from 17% to 23%. This evolution signifies a considerable aging pattern within the U.S. population, with these forecasts emphasizing the growing necessity to cater to the requirements of older individuals in diverse fields. Consequently, the increasing geriatric population is propelling the growth of the gastric ulcers market.

Which Key Segments Fueling The Gastric Ulcers Market?

The gastric ulcersmarket covered in this report is segmented –

1) By Drug Class: Proton Pump Inhibitors (PPI); H2 Antagonists; Antacids; Antibiotics; Cytoprotective Agents; Other Drug Classes

2) By Diagnosis: Stool Test; Endoscopy; Imaging Tests; Computed Tomography (CT) Scan; X-ray; Blood Tests; Other Diagnosis

3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels

5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End Users

Subsegments:

1) By Proton Pump Inhibitors (PPI): Omeprazole; Lansoprazole; Pantoprazole; Esomeprazole; Rabeprazole

2) By H2 Antagonists: Ranitidine; Famotidine; Cimetidine; Nizatidine

3) By Antacids: Calcium Carbonate; Magnesium Hydroxide; Aluminum Hydroxide; Sodium Bicarbonate

4) By Antibiotics: Amoxicillin; Clarithromycin; Metronidazole; Tetracycline

5) By Cytoprotective Agents: Sucralfate; Misoprostol; Bismuth Subsalicylate

6) By Other Drug Classes: Prostaglandin Analogues; Prokinetic Agents; Herbal And Alternative Medications; Combination Therapies

Which Ongoing Trends Are Expected To Shape The Gastric Ulcers Market Outlook?

Leading companies in the gastric ulcer market are concentrating on developing innovative products, including new drug formulations, to improve treatment effectiveness and minimize side effects. New formulation drugs are defined as medicines created with novel combinations of active ingredients, delivery systems, or dosage forms to enhance their efficacy, safety, and patient compliance. For example, in June 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical preparation manufacturing company, introduced Rabeprazole + Levosulpiride SR Capsules, designed to offer superior relief for conditions such as gastro-oesophageal reflux disease (GERD) and other gastrointestinal tract (GIT) disorders. These products combine a proton pump inhibitor and a prokinetic agent, effectively addressing gastrointestinal disorders like gastroesophageal reflux disease (GERD) and gastric ulcers. This particular formulation not only diminishes gastric acid secretion but also boosts gastric motility, delivering comprehensive relief from symptoms such as heartburn and indigestion.

Which Key Players Are Driving Competition In The Gastric Ulcers Market?

Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Amgen Inc., Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

What Are The Key Regional Factors Influencing The Gastric Ulcers Market Growth?

North America was the largest region in the gastric ulcers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Gastric Ulcers Market Report:

https://www.thebusinessresearchcompany.com/customise?id=17160&type=smp

Browse Through More Reports Similar to the Global Gastric Ulcers Market 2025, By The Business Research Company

Gastric Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Gastric Cancer Drugs Global Market 2025

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market

Gastric Volvulus Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Gastric Ulcers Market Through 2034?

In recent times, the market size of gastric ulcers has expanded significantly. The market is expected to escalate from $4.29 billion in 2024 to $4.53 billion in 2025, with a compound annual growth rate (CAGR) of 5.6%. Factors contributing to the growth during the historic period include the increasing incidence of helicobacter pylori infections, the heightened usage of nonsteroidal anti-inflammatory drugs (NSAIDs), the global rise in the aging population, the proliferation of awareness programs to prevent gastric ulcers, and the growing prevalence of stress-related disorders.

Significant expansion is anticipated in the gastric ulcers market in the coming years, with an expected surge to$5.55 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.2%. This expansion during the predicted period can be credited to advancements in diagnostic techniques, the prevalence of unhealthy dietary patterns, progression in treatment methods like proton pump inhibitors (PPIs), an increase in the aging population leading to a higher disease load, and the growth of healthcare infrastructure in upcoming markets. Foreseen trends for the forecasted period incorporate a shift towards combined therapies for improved effectiveness, a growing favor for minimally invasive treatment procedures, the function of digital health remedies in disease control, an increased need for over-the-counter (OTC) ulcer medications, and the broadening of individualized medicine strategies in ulcer treatment.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17160&type=smp

What Are the Core Market Drivers Propelling Growth in the Gastric Ulcers Industry?

The growth of the gastric ulcers market is set to be bolstered by a rising elderly population. This group, typically those aged 65 and over, encounter unique health challenges associated with the aging process. Improvements in healthcare, coupled with dropping birth rates globally, have contributed to an added number of individuals within this demographic. Gastric ulcers are widespread among this group due to increased NSAIDs usage and reduced mucosal protection, subsequently leading to a heightened risk of complications. As an example, projections from the Population Reference Bureau (PRB), a non-profit organization based in the U.S., suggest that by January 2024, the number of Americans enjoying their golden years is set to surge from 58 million in 2022 to an impressive 82 million by 2050, marking an increase of 47%. Furthermore, the ratio of this age group to the total population is projected to climb from 17% to 23%. This shift underscores a marked aging trend among the American populace, thereby emphasizing the growing need to cater to senior citizens across varying sectors. Consequently, the upward trend in the elderly population is fuelling the expansion of the gastric ulcers market.

How Is the Gastric Ulcers Market Segmented?

The gastric ulcersmarket covered in this report is segmented –

1) By Drug Class: Proton Pump Inhibitors (PPI); H2 Antagonists; Antacids; Antibiotics; Cytoprotective Agents; Other Drug Classes

2) By Diagnosis: Stool Test; Endoscopy; Imaging Tests; Computed Tomography (CT) Scan; X-ray; Blood Tests; Other Diagnosis

3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels

5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End Users

Subsegments:

1) By Proton Pump Inhibitors (PPI): Omeprazole; Lansoprazole; Pantoprazole; Esomeprazole; Rabeprazole

2) By H2 Antagonists: Ranitidine; Famotidine; Cimetidine; Nizatidine

3) By Antacids: Calcium Carbonate; Magnesium Hydroxide; Aluminum Hydroxide; Sodium Bicarbonate

4) By Antibiotics: Amoxicillin; Clarithromycin; Metronidazole; Tetracycline

5) By Cytoprotective Agents: Sucralfate; Misoprostol; Bismuth Subsalicylate

6) By Other Drug Classes: Prostaglandin Analogues; Prokinetic Agents; Herbal And Alternative Medications; Combination Therapies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=17160&type=smp

Which Regions Are Driving the Next Phase of the Gastric Ulcers Market Growth?

North America was the largest region in the gastric ulcers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Gastric Ulcers Industry?

Key players in the gastric ulcer market are concentrating on the creation of innovative offerings, like fresh drug formulations, in order to improve treatment effectiveness and mitigate side effects. Novel formulation drugs encompass medicines that feature pioneering blends of active components, conveyance mechanisms, or dosage forms to augment efficacy, safety and patient adherence. For example, Akums Drugs and Pharmaceuticals Ltd., a pharmaceutical preparation enterprise based in India, rolled out Rabeprazole + Levosulpiride SR Capsules in June 2024. This product is intended to offer superior relief for ailments like gastro-oesophageal reflux disease (GERD) and other disorders of the gastrointestinal tract (GIT). These products mix a proton pump inhibitor and a prokinetic agent, efficiently handling gastrointestinal ailments such as GERD and gastric ulcers. This concoction not only decreases gastric acid secretion, but also promotes gastric mobility, offering thorough relief from symptoms like heartburn and indigestion.

View the full report here:

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

How Is the Gastric Ulcers Market Defined and What Are Its Core Parameters?

Gastric ulcers, also known as peptic ulcers, are open sores on the stomach’s inner lining due to the corrosive action of stomach acid. They often cause burning stomach pain, indigestion, and discomfort. Gastric ulcers are usually caused by an imbalance between stomach acid, an enzyme called pepsin, and the protective mucosal barrier lining the stomach and duodenum.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17160

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the gastric ulcers industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Gastric Ulcers Market Size Shifted, And What Is the Outlook Through 2034?

In recent times, considerable growth has been observed in the gastric ulcers market. The market size which presently stands at $4.29 billion in 2024, is predicted to escalate to $4.54 billion in 2025, recording a compound annual growth rate (CAGR) of 5.9%. This substantial growth in the historical period is the result of a number of factors. The increasing incidence of helicobacter pylori infections, the frequent usage of nonsteroidal anti-inflammatory drugs (NSAIDs), the increasing number of elderly people worldwide, the rise in gastric ulcer prevention campaigns, and the growing occurrence of stress-related disorders have all contributed to this growth.

In the coming years, the market for gastric ulcers is predicted to experience robust growth, with its size expected to reach $5.64 billion in 2029, growing at a compound annual growth rate (CAGR) of 5.5%. The expected growth during the projected period can be linked to enhancements in diagnostic methodologies, an increase in unhealthy eating patterns, progress in treatment alternatives such as proton pump inhibitors (PPIs), an aging population which increases the disease load, and the growth of healthcare facilities in developing markets. The future major trends include a shift towards combined therapies for better effectiveness, an increasing inclination towards minimally invasive treatment methods, the incorporation of digital health solutions in managing the disease, a surge in demand for over-the-counter (OTC) ulcer drugs, and the growth of personalized medicine strategies in ulcer therapy.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17160&type=smp

Which Factors and External Forces Are Driving Demand in the Gastric Ulcers Market?

The gastric ulcers market is projected to grow due to the expansion of the geriatric population. People typically over the age of 65 constitute this demographic, which comes with unique healthcare points because of age. This group is growing due to the improvement in healthcare, which increases life expectancy and reduces birth rates worldwide. Gastric ulcers are frequently observed in this age group due to the prevalent use of NSAIDs and a reduction in mucosal protection, which often raises the likelihood of complications. For example, the Population Reference Bureau (PRB), a US-based private non-profit organization, forecasted in January 2024 that the population of Americans aged 65 and older would increase by 47% from 58 million in 2022 to 82 million by 2050. Furthermore, this demographic’s composition of the total population is predicted to grow from 17% to 23%. This shift signifies a substantial increase in the aging trend of the U.S. population. The forecast stresses the need to cater for older adults in different areas. Hence, the growing geriatric population is fuelling the expansion of the gastric ulcers market.

Which Primary Segments of the Gastric Ulcers Market Are Driving Growth and Industry Transformations?

The gastric ulcers market covered in this report is segmented –

1) By Drug Class: Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes

2) By Diagnosis: Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:

1) By Proton Pump Inhibitors (PPI): Omeprazole, Lansoprazole, Pantoprazole, Esomeprazole, Rabeprazole

2) By H2 Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine

3) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate

4) By Antibiotics: Amoxicillin, Clarithromycin, Metronidazole, Tetracycline

5) By Cytoprotective Agents: Sucralfate, Misoprostol, Bismuth Subsalicylate

6) By Other Drug Classes: Prostaglandin Analogues, Prokinetic Agents, Herbal And Alternative Medications, Combination Therapies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=17160&type=smp

What Are the Fastest-Growing Geographies in the Gastric Ulcers Market?

North America was the largest region in the gastric ulcers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Gastric Ulcers Market?

Leading businesses in the gastric ulcer market are concentrating on creating ground-breaking goods, such as novel drug formulations, to increase treatment effectiveness and minimize side effects. New formulation drugs are those that have been crafted with unique combinations of component parts, delivery methods, or dosages to enhance their potency, safety, and patient adherence. For example, in June 2024, Indian pharmaceutical production firm Akums Drugs and Pharmaceuticals Ltd., debuted Rabeprazole + Levosulpiride SR Capsules to offer improved relief for disorders such as gastro-oesophageal reflux disease (GERD) and other gastric tract ailments. These products merge a proton pump inhibitor and a prokinetic agent, successfully managing gastrointestinal issues like GERD and gastric ulcers. This mix not only diminishes gastric acid production but also improves gastric mobility, giving complete relief from symptoms like heartburn and digestion issues.

View the full report here:

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

What Parameters Are Used to Define the Gastric Ulcers Market?

Gastric ulcers, also known as peptic ulcers, are open sores on the stomach’s inner lining due to the corrosive action of stomach acid. They often cause burning stomach pain, indigestion, and discomfort. Gastric ulcers are usually caused by an imbalance between stomach acid, an enzyme called pepsin, and the protective mucosal barrier lining the stomach and duodenum.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17160

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What CAGR Will the Gastric Ulcers Market Achieve During 2025–2034, and What Does It Indicate?

The market size for gastric ulcers has been experiencing considerable growth in the past few years. Predictions for it range from $4.29 billion in 2024 to an increase to $4.54 billion in 2025, with a compound annual growth rate (CAGR) of 5.9%. Factors contributing to this expansion during the historical period include the escalating incidence of helicobacter pylori infections, the augmented consumption of nonsteroidal anti-inflammatory drugs (NSAIDs), the growth of the worldwide elderly population, the progression of awareness initiatives for the prevention of gastric ulcers, and the rising occurrence of disorders linked to stress.

The market size for gastric ulcers is anticipated to witness significant expansion in the coming years. It is projected to reach $5.64 billion by 2029, with a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this growth, forecasted over future years, include enhancements in diagnostic methods, the prevalence of unhealthy eating habits, advances in treatment avenues such as proton pump inhibitors (PPIs), an increase in the elderly population leading to a rise in disease prevalence, and the development of healthcare infrastructure in emerging economies. Other key trends predicted over the forecast period include a shift towards combined treatment therapies for increased effectiveness, a rising predilection for minimally invasive treatment methods, incorporation of digital healthcare solutions in managing the disease, increasing demand for over-the-counter (OTC) ulcer medications, and the widening application of personalized medicine strategies in ulcer therapy.

What Strategic Factors Are Influencing the Accelerated Growth of the Gastric Ulcers Market?

As the elderly population steadily grows, so too does the gastric ulcers market. Typically categorized as those aged 65 years and above, this sector of the population often faces health challenges particular to aging. The rise in this demographic can be attributed to factors such as improved healthcare, longer life spans, and a decrease in birth rates around the globe. Elderly individuals are prone to developing gastric ulcers due to factors like increased NSAIDs use and decreased mucosal protection, thereby heightening complications risk. For example, Population Reference Bureau (PRB), a U.S.-based private non-profit, estimated in January 2024, that the American population of 65 years and older would grow by 47% from 58 million in 2022 to 82 million by 2050. Furthermore, this demographic’s share in the total population is predicted to increase from 17% to 23%, signifying the notable aging trend in the U.S. population. These projections underscore the importance of catering to older adults’ needs across sectors. Hence, the burgeoning geriatric population is the significant driving force behind the growth of the gastric ulcers market.

Explore Comprehensive Insights Into The Global Gastric Ulcers Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17160&type=smp

Who Are the Key Firms Paving the Way for Growth in the Gastric Ulcers Market?

Major companies operating in the gastric ulcers market are:

• Panasonic Corporation_x000D_

• Broadcom Inc._x000D_

• Texas Instruments Incorporated_x000D_

• STMicroelectronics N.V._x000D_

• Infineon Technologies AG_x000D_

What Are the Most Influential Trends Currently Shaping the Gastric Ulcers Market?

Leading businesses in the gastric ulcer market are concentrating on the design and development of groundbreaking products, including unique drug formulations, to better the effectiveness of treatments and mitigate side effects. Newly formulated drugs encompass medications originated from innovative ingredient combinations, delivery mechanisms, or dosages forms to optimize their efficacy, safety, and adherence by patients. For example, Akums Drugs and Pharmaceuticals Ltd., an Indian pharmaceutical preparation producer, introduced Rabeprazole + Levosulpiride SR Capsules in June 2024. This product aims to deliver advanced relief for illnesses such as gastro-oesophageal reflux disease (GERD) and other gastrointestinal tract (GIT) conditions. These products merge a proton pump inhibitor and a prokinetic agent to efficaciously treat gastrointestinal disorders like GERD and gastric ulcers. This recipe not only diminishes gastric acid excretion, but also augments gastric mobility, providing comprehensive relief from symptoms like heartburn and indigestion.

Secure Your Global Gastric Ulcers Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

Which Key Segments of the Gastric Ulcers Market Are Poised for Growth and Innovation?

The gastric ulcers market covered in this report is segmented –

1) By Drug Class: Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes

2) By Diagnosis: Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:

1) By Proton Pump Inhibitors (PPI): Omeprazole, Lansoprazole, Pantoprazole, Esomeprazole, Rabeprazole

2) By H2 Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine

3) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate

4) By Antibiotics: Amoxicillin, Clarithromycin, Metronidazole, Tetracycline

5) By Cytoprotective Agents: Sucralfate, Misoprostol, Bismuth Subsalicylate

6) By Other Drug Classes: Prostaglandin Analogues, Prokinetic Agents, Herbal And Alternative Medications, Combination Therapies

Which Regions Are Essential for the Growth of the Gastric Ulcers Market?

North America was the largest region in the gastric ulcers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Definition of the Gastric Ulcers Market Impacting Future Growth?

Gastric ulcers, also known as peptic ulcers, are open sores on the stomach’s inner lining due to the corrosive action of stomach acid. They often cause burning stomach pain, indigestion, and discomfort. Gastric ulcers are usually caused by an imbalance between stomach acid, an enzyme called pepsin, and the protective mucosal barrier lining the stomach and duodenum.

Browse Through More Similar Reports By The Business Research Company:

Diabetic Foot Ulcer Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diabetic-foot-ulcer-global-market-report

Gastric Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Diabetic Foot Ulcer Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diabetic-foot-ulcer-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: